AZEDRA Trademark

Trademark Overview

On Friday, December 15, 2017, a trademark application was filed for AZEDRA with the United States Patent and Trademark Office. The USPTO has given the AZEDRA trademark a serial number of 87722774. The federal status of this trademark filing is REGISTERED as of Tuesday, July 2, 2019. This trademark is owned by Progenics Pharmaceuticals, Inc.. The AZEDRA trademark is filed in the Pharmaceutical Products category with the following description:

Radiopharmaceutical compositions, namely, imaging and detection agents and therapeutic radiopharmaceutical preparations for treating neuro-endocrine cancers
azedra

General Information

Serial Number87722774
Word MarkAZEDRA
Filing DateFriday, December 15, 2017
Status700 - REGISTERED
Status DateTuesday, July 2, 2019
Registration Number5795290
Registration DateTuesday, July 2, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 26, 2018

Trademark Statements

Description of MarkThe mark consists of the stylized wording "AZEDRA" beneath a design of a triangle without a base forming a stylized letter "A"; the triangle design is formed by multiple smaller triangle designs.
Goods and ServicesRadiopharmaceutical compositions, namely, imaging and detection agents and therapeutic radiopharmaceutical preparations for treating neuro-endocrine cancers
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 2, 2018
Primary Code005
First Use Anywhere DateFriday, May 17, 2019
First Use In Commerce DateFriday, May 17, 2019

Trademark Owner History

Party NameProgenics Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10007
Party NameProgenics Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10007
Party NameProgenics Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10007

Trademark Events

Event DateEvent Description
Tuesday, April 3, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 12, 2018ASSIGNED TO LIE
Tuesday, April 17, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 19, 2017NEW APPLICATION ENTERED
Tuesday, January 2, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 3, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, February 15, 2018ASSIGNED TO EXAMINER
Wednesday, February 28, 2018NON-FINAL ACTION WRITTEN
Wednesday, February 28, 2018NON-FINAL ACTION E-MAILED
Wednesday, February 28, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 17, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 26, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 6, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 26, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 7, 2019SOU TEAS EXTENSION RECEIVED
Thursday, February 7, 2019SOU EXTENSION 1 FILED
Thursday, February 7, 2019SOU EXTENSION 1 GRANTED
Saturday, February 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 22, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, May 29, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 22, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, May 22, 2019SOU EXTENSION 2 FILED
Wednesday, May 29, 2019SOU EXTENSION 2 GRANTED
Wednesday, May 22, 2019USE AMENDMENT FILED
Wednesday, May 29, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 30, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 31, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 2, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, September 16, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, November 13, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 13, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, November 13, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, November 13, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 13, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

azedra radiopharmaceutical treating neuro endocrine cancers preparations agents compositions namely imaging